- Coronary Intervention
- Cardiac Surgery
- Stroke & Carotid Artery Disease
- Peripheral Artery Disease
- Aortic Aneurysm & Dissection
- Varicose Vein & Venous Disease
- Electrophysiology
- Structural Heart Interventions
- Vascular Surgery
- A.V.M. / Uterine Fibroid / Liver Tumor
- Neurovascular Clinic
- Clinical Trials and Research
- Education Programs
- Clinical Programs
- For Women's Hearts
- Noninvasive Cardiac Imaging
|
 |
Lenox Hill Heart and Vascular Institute of New York · Our PhysiciansGary Roubin, MD, PhDChairman, Department of Cardiovascular MedicineAbout Dr. RoubinDr. Gary Roubin, is an internationally renowned interventional cardiologist recognized for his groundbreaking work in the development of the first FDA-approved coronary stent, as well as in pioneering the techniques of carotid stenting and embolic protection devices. Dr. Roubin is currently at Lenox Hill Hospital, where he has been the Chairman of the Department of Interventional Cardiology and Director of the Cardiovascular Interventional Suites since 2004. He has in recent years, committed himself to establishing a new paradigm in cardiovascular care where the full integration and cooperation of interventional cardiologists, vascular surgeons and radiologists will give rise to further innovations and excellence in patient treatment and care. He attended medical school at the University of Queensland where he completed his degree in 1975. He undertook his residency in internal medicine at Royal Prince Alfred Hospital in Sydney, Australia and his cardiology training at the Hallstrom Institute of Cardiology of Sydney University. After completing his cardiology training, he enrolled as a Ph.D. candidate in cardiovascular physiology at Sydney University and was awarded this degree in 1983. In 1983, he was awarded a two-year grant by the National Heart Foundation of Australia to undertake postdoctoral research with Andreas Gruentzig at Emory University. Later he was appointed Director of Research at the Andreas Gruentzig Cardiovascular Center of Emory University. In 1989 he moved to the University of Alabama at Birmingham where he was Professor of Medicine and Radiology and Director of the Cardiac Catheterization Laboratories and Interventional Cardiology Section at the University of Alabama Hospital. In 1995 he was awarded a Doctorate in Medicine from the University of Queensland for his basic and clinical research in the development of coronary stenting. Over the last 20 years, Dr. Roubin's interests have included the development of device technology, innovative techniques for the treatment of coronary and peripheral atherosclerosis and research in the application of coronary angioplasty in patients with multi-vessel coronary disease. He was co-principal investigator in the NHLBI-sponsored EAST study and was the lead U.S. PTCA operator in the NHLBI-sponsored BARI trial, both comparing PCI and bypass surgery in patients with multivessel disease. Currently, he is the Co-Principal Investigator of the NIH/CREST Study comparing stenting and surgery for carotid artery disease. He is a fellow of the American College of Cardiology, a Fellow of the Royal Australian College of Physicians, the Council on Clinical Cardiology of the American Heart Association, the Society for Cardiac Angiography and Intervention, the Society for Vascular Medicine and Biology, the International Society of Endovascular Specialists, Society of Interventional Radiology and the newly formed International Society for Vascular Surgery. Dr. Roubin has published more than 160 papers and 200 abstracts in peer review journals. He has edited two textbooks on interventional cardiovascular medicine, coronary, and carotid artery stenting as well as contributions to 15 textbooks on interventional cardiology. He lectures extensively in the United States and abroad and has received numerous awards for his notable contributions to cardiac care. The pioneering work he does in the catheterization laboratory has been seen live by physicians and healthcare professionals via satellite around the world over the past two decades. Experience
Education & TrainingMedical School
Honors & Awards
Appointments & Memberships
| |||||||||||||
|
|
||||||||||
